BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15809205)

  • 61. [Vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in the blood serum, tumor and renal parenchyma of patients with renal cell carcinoma].
    Trapeznikova MF; Glybin PV; Tumanian VG; Gershteĭn ES; Dutov VV; Kushlinskiĭ NE
    Urologiia; 2010; (4):3-7. PubMed ID: 20973130
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Up-regulation of VEGF and its receptor in refractory leukemia cells.
    Wang L; Zhang W; Ding Y; Xiu B; Li P; Dong Y; Zhu Q; Liang A
    Int J Clin Exp Pathol; 2015; 8(5):5282-90. PubMed ID: 26191229
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
    Aref S; Salama O; Shamaa S; El-Refaie M; Mourkos H
    Hematology; 2007 Aug; 12(4):319-24. PubMed ID: 17654059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
    Kumar SA; Hu X; Brown M; Kuschak B; Hernandez TA; Johnston JB; Gibson SB
    Leuk Lymphoma; 2009 Dec; 50(12):2038-48. PubMed ID: 19860625
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery.
    Jurczyńska J; Stepień T; Lawnicka H; Stepień H; Krupiński R; Kołomecki K; Kuzdak K; Komorowski J
    Endokrynol Pol; 2009; 60(1):9-13. PubMed ID: 19224499
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia.
    Wieczór R; Wieczór AM; Gadomska G; Stankowska K; Fabisiak J; Suppan K; Pulkowski G; Budzyński J; Rość D
    J Zhejiang Univ Sci B; 2016 Nov.; 17(11):842-849. PubMed ID: 27819131
    [TBL] [Abstract][Full Text] [Related]  

  • 67. VEGF and its receptors in dengue virus infection.
    Kalita J; Chauhan PS; Mani VE; Bhoi SK; Misra UK
    J Med Virol; 2015 Sep; 87(9):1449-55. PubMed ID: 25970161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum VEGF-A and VEGFR-1 levels in patients with adult immunoglobulin A vasculitis.
    Yücel Ç; Sertoğlu E; Fırat Oğuz E; Hayran Y; Omma A; Özgürtaş T
    Int J Rheum Dis; 2021 Jun; 24(6):789-794. PubMed ID: 33890417
    [TBL] [Abstract][Full Text] [Related]  

  • 69. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.
    Lee YK; Bone ND; Strege AK; Shanafelt TD; Jelinek DF; Kay NE
    Blood; 2004 Aug; 104(3):788-94. PubMed ID: 14996703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia.
    Aguayo A; O'Brien S; Keating M; Manshouri T; Gidel C; Barlogie B; Beran M; Koller C; Kantarjian H; Albitar M
    Blood; 2000 Jul; 96(2):768-70. PubMed ID: 10887147
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Angiogenic factor VEGF and its relationship with biological prognostic markers in chronic lymphocytic leukemia.
    Ayad MW; El Naggar AA
    Egypt J Immunol; 2010; 17(1):59-71. PubMed ID: 22053610
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
    Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
    J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
    [TBL] [Abstract][Full Text] [Related]  

  • 73. VEGF-A and PDGF-BB--angiogenic factors and the stage of diabetic foot syndrome advancement.
    Drela E; Kulwas A; Jundziłł W; Góralczyk B; Boinska J; Drewniak W; Gadomska G; Rość D
    Endokrynol Pol; 2014; 65(4):306-12. PubMed ID: 25185854
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
    Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
    Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohn's disease patients.
    Pousa ID; Maté J; Salcedo-Mora X; Abreu MT; Moreno-Otero R; Gisbert JP
    Inflamm Bowel Dis; 2008 Jan; 14(1):61-7. PubMed ID: 17879276
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.
    Gehrke I; Gandhirajan RK; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
    Mol Med; 2011; 17(7-8):619-27. PubMed ID: 21519633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma.
    Park DJ; Seo AN; Yoon C; Ku GY; Coit DG; Strong VE; Suh YS; Lee HS; Yang HK; Kim HH; Yoon SS
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1508-15. PubMed ID: 26259755
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Angiogenic factors in blood serum of bone tumor patients.
    Babkina IV; Kuznetsov IN; Soloviev YN; Russo EY; Ten EA
    Klin Lab Diagn; 2013 Oct; (10):63-5, 31-3. PubMed ID: 24640099
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL).
    Aguayo A; Manshouri T; O'Brien S; Keating M; Beran M; Koller C; Kantarjian H; Rogers A; Albitar M
    Leuk Res; 2001 Apr; 25(4):279-85. PubMed ID: 11248324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.